IN THE NEWS

THE LATEST NEWS

Nov 13, 2023

SfN Poster | Genes regulating cytoskeleton organization identified as neuro-common drivers of blood NfL change rate and disease-specific clinical progression in AI driven Digital Twins

Sydley 300x300 1
Nov 09, 2023

Hear What Colin Hill had to say to Sidley on AI Use in Drug Discovery

Nov 08, 2023

Cytoskeleton Genes Underlying Onset and Progression in Multiple Neurodegenerative Disorders Discovered through Aitia’s Digital Twins to be Presented at SfN 2023

Oct 19, 2023

Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023

Sep 27, 2023

Aitia and Pancreatic Cancer Action Network Partner to Transform De-Identified Multi-Omic Patient Data into Digital Twins to Drive New Discoveries and Improve Patient Outcomes

Webinar Video
Sep 20, 2023

Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease

Sep 19, 2023

Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer

67 300x300 1
Aug 10, 2023

Exploring the Frontiers of AI-driven Drug Discovery: A Conversation with Aitia on The Long Run Podcast

ServierAitia
Aug 03, 2023

Servier and Aitia Mobilize AI and Digital Twins to Treat Pancreatic Cancer

Screenshot 2023 06 28 at 12.13.02 PM
Jun 28, 2023

Colin Hill Weighs in on the Future of Drug Discovery on the Patients Rising Podcast